Independent Review of EASL 2015

EASL15_Brazil 

Launch-On-Demand-Program-Brazil-button.jpg

About the Program

Program Overview

The Advances in Chronic Hepatitis C: Management and Treatment program is a comprehensive, expert review of the 50th Annual Meeting of the European Association for the Study of the Liver (EASL 2015). This program consists of five components: (1) CME Internet Symposium: EASL 2015 Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) CME Internet Symposium: European Perspective on EASL 2015: a 1-hour Internet symposium featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in the EU; (3) CME Internet Symposium: Brazilian Perspective on EASL 2015: a 1-hour Internet symposium featuring Brazil-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in Brazil; (4) Rapid-Fire Review of EASL 2015: a podcast that provides a brief, audio summary of the essential data presented at the conference; and (5) From Conference to Clinic: Reviewing and Applying Data from EASL 2015: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care. The CME Internet Symposium: Brazilian Perspective on EASL 2015 will provide a Brazilian focused review and discussion of the key studies on chronic hepatitis C presented at EASL 2015. The expected result is that Brazil-based participants will not only gain an increased understanding of key data presented at EASL 2015, they will also be better prepared to address their HCV patients’ health needs and provide optimal care, which should improve treatment and adherence, increase individualized care, reduce adverse effects and drug-drug interactions, and improve quality of life for people with chronic hepatitis C throughout Brazil.

All online components of the program will be accessible at www.viraled.com.

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EASL 2015 and it is not sanctioned by the organizers of EASL 2015.

 

Back to Top   

Target Audience

This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals in Brazil involved in the
treatment and management of patients with HCV infection.

Back to Top

Learning Objectives

After completing this activity, the participant should be better able to:

  • Use in a clinical setting in Brazil, important findings from key studies on CHC diagnosis and treatment presented at EASL 2015

  • Employ the current treatment paradigms for CHC applicable in Brazil, including the studies and data presented at EASL 2015 to improve patient care

  • Discuss with patients and colleagues how the studies and data on newer therapies for CHC presented at EASL 2015 affect appropriate planning of therapy for patients with CHC in Brazil

Release Date: May 4, 2015

Expiration Date: May 4, 2016

Estimated time to complete the EASL 2015 Brazil Internet Symposium: 1 hour, 15 minutes 

Media: Internet

 

Back to Top

Faculty

Mário G. Pessoa, MD, PhD
Assistant Professor
Division of Gastroenterology and Hepatology
University of São Paulo School of Medicine
São Paulo, Brazil

Mauro Schechter, MD, PhD
Professor of Infectious Diseases
Department of Preventive Medicine
Federal University of Rio de Janeiro, Brazil
Rio de Janeiro, Brazil

Back to Top  

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to provideing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commerical interest.

Mario Pessoa, MD
  • Consulting Fees: Abbvie, Roche, Janssen, BMS, Gilead, Merck
  • Fees for Non-CME/CE Services: Abbvie, Roche, Janssen, BMS, Gilead, Merck
  • Contracted Research: Abbvie

Mauro Schechter, MD

  • Consulting Fees: Achillion, BMS, Gilead, Abbvie, Merck, Janssen, Roche
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Judi Smelker-Mitchek, RN, BSN; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Shultz, RN, MSN, CCMEP and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.

Back to Top

Instructions for Participation and Credit

 

There are no fees for participating and receiving CME credit for this activity. During the period, May 4, 2015 through May 4, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 10851.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclosure of Unlabeled Use

 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer

 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.  

Back to Top

 


 

PIM_small

This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EASL 2015 and it is not sanctioned by EASL 2015.


Prepare to print

Share this page:

Get link code to this page                     


Back to Top